National Comprehensive Cancer Network Guideline Recommendations of Cancer Drugs With Accelerated Approval

IMPORTANCE: Many cancer drugs are approved under the US Food and Drug Administration (FDA) accelerated approval pathway based on preliminary evidence. It is unclear how this limited evidence is integrated into the National Comprehensive Cancer Network (NCCN) guidelines, which are common references f...

Descripción completa

Detalles Bibliográficos
Autores principales: Cliff, Edward R. Scheffer, Rome, Rachel S., Kesselheim, Aaron S., Rome, Benjamin N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646727/
https://www.ncbi.nlm.nih.gov/pubmed/37962889
http://dx.doi.org/10.1001/jamanetworkopen.2023.43285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646727/
https://www.ncbi.nlm.nih.gov/pubmed/37962889
http://dx.doi.org/10.1001/jamanetworkopen.2023.43285

Ejemplares similares